Nonsteroidal antiestrogens: their biological effects and potential mechanisms of action
- PMID: 207880
- DOI: 10.1080/15287397809529666
Nonsteroidal antiestrogens: their biological effects and potential mechanisms of action
Abstract
The uterotropic and antiuterotrapic effects of a variety of structural derivatives of the nonsteroidal antiestrogen tamoxifen have been determined in the rat and the mouse. One derivative, monohydroxytamoxifen, was found to be a potent antiestrogen in the rat, with a high affinity for the estrogen receptor. Various techniques of sucrose density gradient analysis were used to demonstrate that estradiol and tamoxifen bind to the rat uterine cytoplasmic estrogen receptor. Estrogens and antiestrogens provoke the translocation of estrogen receptors to the nucleus and deplete the cytoplasmic estrogen receptor pool for short or long periods depending on the dose administered. Estradiol stimulates endometrial hyperplasia with an increase in total uterine DNA content, whereas tamoxifen stimulates endometrial hypertrophy with only a slight increase in uterine DNA content. It is concluded that the molecular shape of the ligand that binds to the estrogen receptor determines antiestrogenic activity.
Similar articles
-
Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018.Endocrinology. 1983 Aug;113(2):463-8. doi: 10.1210/endo-113-2-463. Endocrinology. 1983. PMID: 6872937
-
Antiestrogen pharmacology and mechanism of action.J Steroid Biochem. 1983 Jul;19(1A):59-68. J Steroid Biochem. 1983. PMID: 6887873
-
Antiestrogen action in the uterus: biological ineffectiveness of nuclear bound estradiol after antiestrogen.Endocrinology. 1975 Jul;97(1):1-12. doi: 10.1210/endo-97-1-1. Endocrinology. 1975. PMID: 166821
-
Basic guide to the mechanisms of antiestrogen action.Pharmacol Rev. 1998 Jun;50(2):151-96. Pharmacol Rev. 1998. PMID: 9647865 Review.
-
Cellular and molecular pharmacology of antiestrogen action and resistance.Pharmacol Rev. 2001 Mar;53(1):25-71. Pharmacol Rev. 2001. PMID: 11171938 Review.
Cited by
-
Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer.Breast Cancer Res Treat. 1995;36(3):267-85. doi: 10.1007/BF00713399. Breast Cancer Res Treat. 1995. PMID: 8573710 Review.
-
A study on the effect of a single dose of tamoxifen on uterine hyperaemia and growth in the rat.Br J Pharmacol. 1987 Oct;92(2):429-35. doi: 10.1111/j.1476-5381.1987.tb11339.x. Br J Pharmacol. 1987. PMID: 3676603 Free PMC article.
-
Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance.Breast Cancer Res Treat. 1982;2(2):123-38. doi: 10.1007/BF01806449. Breast Cancer Res Treat. 1982. PMID: 6184101 Review.
-
Linking estrogen-induced apoptosis with decreases in mortality following long-term adjuvant tamoxifen therapy.J Natl Cancer Inst. 2014 Sep 30;106(11):dju296. doi: 10.1093/jnci/dju296. Print 2014 Nov. J Natl Cancer Inst. 2014. PMID: 25269699 Free PMC article.
-
Long-term adjuvant tamoxifen therapy for breast cancer.Breast Cancer Res Treat. 1990 May;15(3):125-36. doi: 10.1007/BF01806350. Breast Cancer Res Treat. 1990. PMID: 2196941 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources